Stocks
Illumina, Inc.ILMN
NASDAQHealthcareLife Sciences Tools & Services$118.94+2.92%
A major provider of DNA sequencing systems and related consumables used in genomic research, clinical laboratories, and drug development. Its platforms and reagents enable large-scale analysis of genetic material, making the company a central supplier to biotechnology firms, academic institutions, a...
Market Cap: $18.2B52W Range: $68.70 – $155.53
Congressional Interest in Illumina, Inc. (ILMN)
8 members of Congress have disclosed 18 trades in Illumina, Inc. (ILMN), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 11 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
18
Unique Politicians
8
Buys
7
Sells
11
Who in Congress Is Trading ILMN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-08-02 | MICHAEL T. MCCAUL | buy | $50K – $100K |
| 2016-06-23 | MICHAEL T. MCCAUL | sell | $1K – $15K |